Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D07WDS
|
|||
| Former ID |
DIB013625
|
|||
| Drug Name |
NNC-14-0189
|
|||
| Indication | Epilepsy [ICD-11: 8A60-8A68] | Terminated | [1] | |
| Company |
Novo Nordisk A/S
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C20H20FN7O
|
|||
| Canonical SMILES |
CN1CCN(CC1)C2=NC3=C(N=CN3C4=C2C=C(C=C4)F)C5=NOC(=N5)C6CC6
|
|||
| InChI |
1S/C20H20FN7O/c1-26-6-8-27(9-7-26)18-14-10-13(21)4-5-15(14)28-11-22-16(19(28)24-18)17-23-20(29-25-17)12-2-3-12/h4-5,10-12H,2-3,6-9H2,1H3
|
|||
| InChIKey |
HIBQQLJKYMSZOZ-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800005804) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.